FY2027 Earnings Forecast for Chinook Therapeutics, Inc. (NAS

Chinook Therapeutics, Inc. (NASDAQ:KDNY – Get Rating) – Stock analysts at HC Wainwright upped their FY2027 earnings per share (EPS) estimates for shares of Chinook Therapeutics in a research report issued to clients and investors on Wednesday, May 10th. HC Wainwright analyst E. Arce now forecasts that the company will post earnings per share of […]

Related Keywords

Hong Kong , Piper Sandler , Eric Dobmeier , Tom Frohlich , Allspring Global Investments Holdings , Nasdaq , Chinook Therapeutics Inc , Tower Research Capital , Hong Kong Ltd , Lazard Asset Management , Chinook Therapeutics , Get Rating , Chinook Therapeutic , Kong Ltd , Global Investments Holdings , Asset Management , Research Capital , Chinook Therapeutics Daily , Nasdaq Kdny , Akdny , Medical , Earnings Estimates , Hc Wainwright ,